Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Triple Negative Breast Neoplasms 3 Solid Tumor, Adult 1 Colorectal Neoplasms 1

Interventions

Bevacizumab 119 Fluorouracil 91 Leucovorin 83 Cetuximab 83 Oxaliplatin 80 pembrolizumab 71 Irinotecan 67 Nivolumab 45 Capecitabine 43 Specimen Handling 40 regorafenib 30 trifluridine tipiracil drug combination 29 Folfox protocol 29 Magnetic Resonance Spectroscopy 27 Biopsy 27 Panitumumab 26 Standard of Care 25 HMPL-013 25 IFL protocol 20 Gemcitabine 20 Trifluridine 19 Cisplatin 19 Blood Specimen Collection 19 tislelizumab 17 atezolizumab 17 Carboplatin 17 balstilimab 16 Colonoscopy 16 encorafenib 15 Paclitaxel 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Colorectal Neoplasms × leronlimab × 1 year × Clear all

NCT06699836 2026-05-18

CLOVER

CytoDyn, Inc.

Phase 2 Active not recruiting

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡